Brain cancer breakthrough? immune cell therapy shows promise in phase 3 trial
NCT ID NCT00807027
First seen Nov 01, 2025 · Last updated Jun 16, 2026 · Updated 33 times
Summary
This study tested whether adding an immune cell therapy called Immuncell-LC to standard chemotherapy (temozolomide) helps people with newly diagnosed glioblastoma, an aggressive brain cancer. 180 adults in Korea participated. The goal was to see if the combination slowed cancer growth better than chemotherapy alone. While the treatment aims to control the disease, it is not a cure, as ongoing management is needed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gyunghee University Medical Center
Seoul, South Korea
-
Hanyang University Guri Hospital
Guri-si, Gyeonggi-do, South Korea
-
Konkuk University
Seoul, South Korea
-
Korea University Anam Hospital
Seoul, South Korea
-
Samsung Seoul Medical Center
Seoul, South Korea
-
Seoul Asan Medical Center
Seoul, South Korea
-
Yeonsei University Medical Center
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.